Dialogue Technologies acquires DXA
Dialogue Technologies, a virtual healthcare platform, has announced that it has completed the acquisition of DXA, a company that has developed an AI-driven medical technology platform.
In a Nov. 9 announcement, Dialogue stated that the acquisition will enable it to improve the efficiency of its services and explore partnership opportunities with healthcare providers and insurers.
“This platform can be used by telehealth, ER and clinic providers to automate triage and the clinical chart note all while improving the patient’s journey throughout their care,” said Dr. Jonah Hebert-Davies, one of DXA’s founders who also works as an Orthopedic Trauma Surgeon at Harborview Medical Center of the University of Washington in Seattle.
“It can even be integrated to most electronic medical records and can also be a very helpful health risk evaluation tool for insurance carriers.”
Complements virtual care platform
“This technology has the potential to revolutionize how people access healthcare and will generate substantial efficiencies for healthcare providers,” said Cherif Habib, co-founder and CEO of Dialogue. “It complements our virtual care platform and will allow Dialogue to equip hospitals, clinics and insurers with a cutting-edge technology that can significantly increase efficiency and accuracy while also reducing costs.”